Hypofractionated Radiotherapy with Sequential Anthracycline-based Chemotherapy in Marginally Resectable Soft Tissue Sarcomas: Final Results of a Phase II Clinical Trial

被引：0
|
作者：
Spalek, M. [1 ]
Kosela-Paterczyk, H. [1 ]
Borkowska, A. [1 ]
Wagrodzki, M. [2 ]
Szumera-Cieckiewicz, A. [2 ]
Czarnecka, A. M. [1 ,3 ]
Castaneda-Wysocka, P. [4 ]
Dabrowska-Szewczyk, E. [5 ]
Cieszanowski, A. [4 ]
Rutkowski, P. [1 ]
机构：
[1] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Soft Tissue Bone Sarcoma & Melanoma, Warsaw, Poland
[2] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Pathol, Warsaw, Poland
[3] Polish Acad Sci, Dept Expt Pharmacol, Mossakowski Med Res Ctr, Warsaw, Poland
[4] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Radiol 1, Warsaw, Poland
[5] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Med Phys, Warsaw, Poland
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2020年 / 108卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1031
引用
收藏
页码：S131 / S131
页数：1
相关论文
共 50 条
  • [41] FINAL RESULTS OF A PHASE-III CLINICAL-TRIAL OF ADJUVANT CHEMOTHERAPY WITH THE MODIFIED FLUOROURACIL, DOXORUBICIN, AND MITOMYCIN REGIMEN IN RESECTABLE GASTRIC-CANCER
    LISE, M
    NITTI, D
    MARCHET, A
    SAHMOUD, T
    BUYSE, M
    DUEZ, N
    FIORENTINO, M
    DOSSANTOS, JG
    LABIANCA, R
    ROUGIER, P
    GIGNOUX, M
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (11) : 2757 - 2763
  • [42] A Phase II Trial of Radiotherapy Concurrent with Apatinib in Locally Advanced Bone and Soft Tissue Sarcoma of the Head and Neck: Preliminary Results
    Ye, L. L.
    Li, R.
    Dou, S.
    Shao, Z.
    Ji, T.
    Zhu, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S131 - S132
  • [43] Safety and Activity Report of a Randomized Phase II Trial of Preoperative Anthracycline-Based Chemotherapy Plus Lapatinib, Trastuzumab or Both in HER2 Positive Breast Cancer: CHERLOB Trial
    Guarneri, V
    Frassoldati, A.
    Bottini, A.
    Cagossi, K.
    Piacentini, F.
    Ravaioli, A.
    Cavanna, L.
    Amadori, D.
    Bisagni, G.
    Giardina, G.
    Conte, P.
    CANCER RESEARCH, 2009, 69 (24) : 568S - 569S
  • [44] Preoperative Dose-Escalated Intensity-Modulated Radiotherapy (IMRT) and Intraoperative Radiation Therapy (IORT) in Patients with Retroperitoneal Soft-Tissue Sarcoma: Final Results of a Clinical Phase I/II Trial
    Seidensaal, Katharina
    Dostal, Matthias
    Kudak, Andreas
    Jaekel, Cornelia
    Meixner, Eva
    Liermann, Jakob
    Weykamp, Fabian
    Hoegen, Philipp
    Mechtersheimer, Gunhild
    Willis, Franziska
    Schneider, Martin
    Debus, Juergen
    CANCERS, 2023, 15 (10)
  • [45] IMMUNOSARC: A collaborative Spanish (GEIS) and Italian (ISG) sarcoma groups phase I/II trial of sunitinib plus nivolumab in advanced soft tissue and bone sarcomas: Results of the phase II-soft-tissue sarcoma cohort
    Martin Broto, J.
    Hindi, N.
    Grignani, G. E.
    Martinez Trufero, J.
    Redondo, A.
    Valverde, C.
    Lopez Pousa, A.
    Stacchiotti, S.
    Palmerini, E.
    de Alava, E.
    Moura, D. S.
    Perez Vega, H.
    Collini, P.
    Otero, I.
    Ledesma, P.
    Marchesi, E.
    D'Ambrosio, L.
    Lopez Martin, J. A.
    ANNALS OF ONCOLOGY, 2019, 30 : 684 - 684
  • [46] Imatinib mesylate in soft tissue and bone sarcomas: Interim results of a Sarcoma Alliance for Research thru Collaboration (SARC) phase II trial.
    Chung, RK
    Thomas, D
    Wathen, K
    Thall, PF
    Benjamin, RS
    Maki, RS
    Samuels, BL
    Keohan, ML
    Priebat, DA
    Baker, LH
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 818S - 818S
  • [47] Multicenter phase II study of pembrolizumab (P) in advanced soft tissue (STS) and bone sarcomas (BS): Final results of SARC028 and biomarker analyses
    Burgess, Melissa Amber
    Bolejack, Vanessa
    Van Tine, Brian Andrew
    Schuetze, Scott
    Hu, James
    D'Angelo, Sandra P.
    Attia, Steven
    Priebat, Dennis A.
    Okuno, Scott H.
    Riedel, Richard F.
    Davis, Lara Emily
    Mowa, Sujana
    Reed, Damon R.
    Butterfield, Lisa Helene
    Roszik, Jason
    Reinke, Denise K.
    Baker, Laurence H.
    Maki, Robert G.
    Patel, Shreyaskumar
    Tawbi, Hussein Abdul-Hassan
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [48] Results of the LMS03 phase II study evaluating gemcitabine combined with pazopanib as a 2nd-line treatment for metastatic/relapsed leiomyosarcomas (uterine or soft tissue) after failure of anthracycline-based chemotherapy: The UNICANCER SARCOME 11 study
    Pautier, P.
    Penel, N.
    Ray-Coquard, I.
    Italiano, A.
    Bompas, E.
    Delcambre, C.
    Bay, J-O.
    Bertucci, F.
    Delaye, J.
    Chevreau, C.
    Cupissol, D.
    Le Moal, L. Bozec
    Eymard, J-C.
    Thyss, A.
    Isambert, N.
    Guillemet, C.
    Rios, M.
    Piperno-Neumann, S.
    Chenuc, G.
    Duffaud, F.
    ANNALS OF ONCOLOGY, 2017, 28
  • [49] NEOADJUVANT VIDUTOLIMOD (VIDU) AND NIVOLUMAB (NIVO) RESULTS IN MPR AND IMMUNE ACTIVATION IN HIGH-RISK RESECTABLE MELANOMA (MEL): FINAL PHASE II CLINICAL TRIAL RESULTS
    Karunamurthy, Arivarasan
    Chauvin, Joe-Marc
    Morrison, Robert
    Bai, Yulong
    Sun, Jie
    Wang, Hong
    Hartman, Douglas
    Stein, Julie
    Deitrick, Christopher
    Bao, Riyue
    Singh, Jagjit
    Ding, Quanquan
    Gao, Wentao
    Hurd, Drew
    Pagliano, Ornella
    Rose, Amy
    Najjar, Yana
    Luke, Jason
    Mauro, David
    Krieg, Arthur
    Wooldridge, James
    Bobilev, Dmitri
    Kirkwood, John
    Taube, Janis
    Park, Hyun Jung
    Zarour, Hassane
    Davar, Diwakar
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A634 - A635
  • [50] A phase I/II trial of neoadjuvant pegylated arginine deiminase (ADI-PEG 20) with ifosfamide and radiotherapy in soft tissue sarcomas (STS) of the trunk or extremity
    Weiss, Mia C.
    Haarberg, Sasha
    Luo, Chongliang
    Hirbe, Angela C.
    Apicelli, Anthony J.
    English, D. Ian
    Van Tine, Brian Andrew
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345